NKG2D expression on HIV-specific CD8+ T cells is reduced in viremic HIV-1-infected patients but maintained in HIV controllers - Institut Pasteur Access content directly
Journal Articles Journal of Acquired Immune Deficiency Syndromes - JAIDS Year : 2013

NKG2D expression on HIV-specific CD8+ T cells is reduced in viremic HIV-1-infected patients but maintained in HIV controllers

Abstract

NKG2D mediates an important costimulatory pathway in CD8 T cells. In HIV infection, the authors found that NKG2D expression on both total CD8 and HIV-specific CD8 T cells was significantly lower in viremic patients than in HIV controllers. Antiretroviral therapy partially restored NKG2D expression on HIV-specific CD8 T cells. The authors observed a negative correlation between the respective expression levels of CD38 and NKG2D on total CD8 and HIV-specific CD8 T cells. The maintenance of NKG2D expression on CD8 T cells in HIV controllers may contribute to better cell function.
Fichier principal
Vignette du fichier
JAIDS Lambotte NKG2D revised.pdf (113.19 Ko) Télécharger le fichier
Origin Files produced by the author(s)
Loading...

Dates and versions

pasteur-01420533 , version 1 (16-05-2017)

Licence

Identifiers

Cite

Camille Lecuroux, Asier Saez-Cirion, Nicolas Noel, Lilia Ben-Lamine, Isabelle Girault, et al.. NKG2D expression on HIV-specific CD8+ T cells is reduced in viremic HIV-1-infected patients but maintained in HIV controllers. Journal of Acquired Immune Deficiency Syndromes - JAIDS, 2013, 62 (1), pp.17--20. ⟨10.1097/QAI.0b013e318274579f⟩. ⟨pasteur-01420533⟩
373 View
370 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More